InBios International Gets $12.7M Contract to Boost Rapid Covid-19 Test Production
The contract enables InBios to ramp up production of the covid-19 tests to 400,000 units per week – 20 times the facility’s current output – by May 2021.
Read MorePosted by Melanie Hamilton-Basich | Nov 13, 2020 | Covid 19 |
The contract enables InBios to ramp up production of the covid-19 tests to 400,000 units per week – 20 times the facility’s current output – by May 2021.
Read MorePosted by Melanie Hamilton-Basich | Nov 13, 2020 | Biochemicals & Chemical Reagents, Covid 19, Labwear & Consumables |
Laboratories are having to limit other types of testing because they only have so many supplies, and covid-19 testing is taking priority.
Read MorePosted by Melanie Hamilton-Basich | Nov 12, 2020 | Covid 19, Lab Management |
Continued covid-19 testing demand is exacerbating longstanding staffing shortages at laboratories and leading to employee burnout, reports the Wall Street Journal.
Read MorePosted by Melanie Hamilton-Basich | Nov 12, 2020 | Covid 19, Diagnostic Technologies |
The Covid-19 At-Anywhere Diagnostics Design-a-thon challenges participants to develop technical innovations to help fight covid-19.
Read MorePosted by Laurie Bonner | Nov 12, 2020 | Covid 19, Point-of-Care |
The BD Veritor Plus System has been authorized for use by Health Canada under an interim order.
Read More